Search results
Results from the WOW.Com Content Network
Biotechnology. Abgent; Acadia Pharmaceuticals; ... Top companies in the San Diego metro area on the 2012 Inc. 5000 This page was last edited on 3 February 2025 ...
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process . Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
Helix is headquartered in the San Francisco Bay Area and operates a sequencing laboratory in San Diego. [ 3 ] In 2016, Helix partnered with the National Geographic Society to sequence DNA for the Genographic Project .
Arena Pharmaceuticals Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. Arena focused on discovering drugs that act on G protein-coupled receptors (GPCRs). The company developed technology it called Constitutively Activated Receptor Technology (CART) that identified drug leads targeting ...
Calico, short for the California Life Company, [1] [2] was announced on September 18, 2013, prior to Google's restructuring and was founded by former GV CEO Bill Maris. [3] [4] In Google's 2013 Founders Letter, Larry Page described Calico as a company focused on "health, well-being, and longevity."
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. [2]
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. [1] It was founded in 2008 by Osman Kibar. [2] Samumed's products in development target novel components of the Wnt signaling pathway.